American International Group, Inc. Inhibrx, Inc. Transaction History

American International Group, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$32.76 - $39.56 $4,750 - $5,736	-145 Reduced 0.85%	16,926 $591,000
Q4 2023 Feb 13, 2024	SELL	$14.5 - $38.0 $1,000 - $2,622	-69 Reduced 0.4%	17,071 $648,000
Q3 2023 Nov 13, 2023	BUY	$15.75 - $26.31 $9,607 - $16,049	610 Added 3.69%	17,140 $314,000
Q2 2023 Aug 04, 2023	BUY	$16.96 - $27.82 $13,669 - $22,422	806 Added 5.13%	16,530 $429,000
Q1 2023 May 12, 2023	BUY	$18.45 - $27.14 $5,774 - $8,494	313 Added 2.03%	15,724 $296,000
Q4 2022 Feb 10, 2023	BUY	$20.18 - $33.33 $31,319 - $51,728	1,552 Added 11.2%	15,411 $379,000
Q3 2022 Nov 14, 2022	BUY	$11.58 - $24.73 $2,258 - $4,822	195 Added 1.43%	13,859 $249,000
Q2 2022 Aug 12, 2022	SELL	$8.52 - $25.26 $1,661 - $4,925	-195 Reduced 1.41%	13,664 $155,000
Q1 2022 May 13, 2022	SELL	$19.89 - $43.18 $19,412 - $42,143	-976 Reduced 6.58%	13,859 $309,000
Q4 2021 Feb 11, 2022	SELL	$26.75 - $46.02 $11,850 - $20,386	-443 Reduced 2.9%	14,835 $648,000
Q3 2021 Nov 12, 2021	SELL	$25.18 - $37.81 $9,165 - $13,762	-364 Reduced 2.33%	15,278 $509,000
Q2 2021 Aug 13, 2021	BUY	$14.69 - $27.52 $160,194 - $300,105	10,905 Added 230.21%	15,642 $430,000
Q1 2021 May 07, 2021	BUY	$16.27 - $41.26 $195 - $495	12 Added 0.25%	4,737 $95,000
Q4 2020 Feb 12, 2021	BUY	$15.96 - $50.0 $75,411 - $236,250	4,725 New	4,725 $156,000

25.3K

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $617M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.